Steven Cohen’s ProKidney PROK Stock Holding History

Steven Cohen’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-65,578	Closed	-$117K	–	4469
2026 Q1	$117K	Buy	65,578 +48,491	+284%	+$103K	﹤0.01%	3593
2025 Q4	$38.3K	Buy	+17,087	New	+$44.9K	﹤0.01%	3801

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steven Cohen's PROK Position: Q2 2026 in Review

Steven Cohen sold out of ProKidney (PROK) in Q2 2026, closing a stake of 65,578 shares — an estimated $117K sold.

Steven Cohen first reported a position in PROK in Q4 2025 and held it in 2 quarters. The position peaked at $117K in Q1 2026. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

Steven Cohen reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 65,578 ProKidney shares in Q2 2026, an estimated $117K.
Steven Cohen first reported a position in ProKidney in Q4 2025 and held it in 2 quarters.
Steven Cohen's ProKidney position peaked at $117K in Q1 2026.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.